ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.44
-0.52%
US Tech 100
21,191.20
0.62%
S&P 500
6,051.09
0.00%
US Dollar vs CAD
1.42365
0.00%
Bitcoin
101,776.59
0.37%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Nkarta Inc (NKTX)

  7. Nkarta Inc (NKTX) News

NKTX

Nkarta (NKTX)

Nkarta Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NKTX
DateTimeSourceHeadlineSymbolCompany
12/05/20245:01AMGlobeNewswire Inc.Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2NASDAQ:NKTXNkarta Inc
11/26/20246:02AMGlobeNewswire Inc.Nkarta to Participate in an Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
11/14/20243:05PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NKTXNkarta Inc
11/12/20247:02AMGlobeNewswire Inc.Nkarta to Participate in an Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
11/08/20241:17PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:NKTXNkarta Inc
11/07/20243:21PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NKTXNkarta Inc
11/07/20243:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
11/07/20243:02PMGlobeNewswire Inc.Nkarta Reports Third Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
10/25/20248:44PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NKTXNkarta Inc
10/25/20248:44PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NKTXNkarta Inc
09/03/20243:01PMGlobeNewswire Inc.Nkarta to Participate in Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
08/23/20243:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
08/13/20248:03PMGlobeNewswire Inc.Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
08/13/20243:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NKTXNkarta Inc
08/13/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
08/13/20243:01PMGlobeNewswire Inc.Nkarta Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
07/31/20243:48PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
07/31/20243:47PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
07/31/20243:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
07/24/20245:00AMGlobeNewswire Inc.Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus ErythematosusNASDAQ:NKTXNkarta Inc
07/16/20245:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
07/16/20245:01AMGlobeNewswire Inc.Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as PresidentNASDAQ:NKTXNkarta Inc
06/27/20245:00AMGlobeNewswire Inc.Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune IndicationsNASDAQ:NKTXNkarta Inc
06/14/20243:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
06/14/20243:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
06/14/20243:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
06/14/20243:04PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
06/13/20243:22PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
06/13/20243:01PMGlobeNewswire Inc.Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of DirectorsNASDAQ:NKTXNkarta Inc
05/09/20243:14PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NKTXNkarta Inc
 Showing the most relevant articles for your search:NASDAQ:NKTX

Your Recent History

BOV
HETA3T
HERCULES
BIT
P1P0O5
BNP Paribas Issuance
AQSE
KNDR
Kondor AI
BIT
S29326
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved